Pay in 4 interest-free payments of $6.69 Learn more
Ships within 48 hours · Estimated delivery Oct 1 - Oct 6
Early clinical data have generated significant scientific interest, particularly for the treatment of obesity and type 2 diabetes
Because retatrutide is not yet licensed, all dosing and timing must follow the trial protocol under which it is being administered
Food and Drug Administration Novo Nordisk
Depending on your individual circumstances, healthcare professionals may recommend: Dietary and lifestyle interventions Structured weight management programmes Assessment for underlying medical conditions Evidence-based treatment options that are legally available and clinically appropriate Final Message Retatrutide is currently not registered with the Drug Control Authority (DCA) Malaysia and is not legally available for sale through licensed pharmacies in Malaysia at the time of writing
US$ 20.41
US$ 23.03
US$ 26.91
US$ 22.50
US$ 29.77
